For patient advocates and health economists, cases like Ekirch’s illustrate why prior authorization has become such a chronic ...

Cigna is positioned to benefit from utilization normalization and aims for 10%-14% annual EPS growth. See why I rate CI stock a buy at current prices.

Ekirch said specialists have suggested that a series of infusions made from blood plasma called intravenous immunoglobulin -- ...

Cigna (CI) CEO David Cordani is not convinced of the benefits of GLP-1s for weight-loss patients and said the US is the only country among developed nations where insurance coverage is being debated.

StockNews.com upgraded shares of The Cigna Group (NYSE:CI – Free Report) from a buy rating to a strong-buy rating in a research note released on Saturday morning. CI has been the topic of several ...

But he was determined to make it to Paris for the exhibition of his life. David Hockney in 1987 at his home in Los Angeles, Calif. This month Louis Vuitton Foundation in Paris opens a ...